 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123 |
- | Corvert (ibutilide) / Pfizer, Brinavess (vernakalant) / Merck (MSD), Correvio
New P4 trial: Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation (clinicaltrials.gov) - Oct 4, 2011
P4, N=100, Recruiting, Sponsor: Medical University of Vienna